使用聚米克辛治疗多药耐药病原体的临床治疗进展
Yizhen Huang1, Mingrui Liao2, Xuzhi Hu2
1Department of Pharmacy, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang 321000, China.
The Journal of antimicrobial chemotherapy
|October 1, 2024
概括
聚米克辛有效治疗耐多药性格拉姆阴性细菌感染,包括耐卡巴胺菌株. 配方和管理方面的进步提高了有效性,同时控制了毒性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 聚米克辛对于治疗多抗药性格拉姆阴性细菌至关重要.
- 毒性和替代治疗方法限制了多素的使用.
- 耐卡巴胺的克拉姆阴性细菌 (CR-GNB) 感染构成了日益严重的威胁.
研究的目的:
- 复习多素的特性.
- 检查治疗CR-GNB感染的临床进展.
- 评估治疗的有效性和安全性.
主要方法:
- 对polymyxin属性的文献分析.
- 临床方法的审查:静脉输注,吸入,局部.
- 对细菌根除,治愈和死亡率的评估.
主要成果:
- 在关键的CR-GNB感染中,多基因正在重新出现.
- 通过适当的配方和管理,证实了有效的治疗方法.
- 观察到可接受的毒性水平.
结论:
- 未来的多菌素开发目标是提高疗效和降低毒性.
- 预防多素耐药性是一个关键目标.
- 新的交付系统 (受控发布,定制管理) 可以提高结果.
更多相关视频
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
4.5K
06:42Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
1.6K
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Antibiotic Selection
52.4K
Overview
52.4K
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Pneumonia IV: Management
305
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
305
